LRa05 (Lacticaseibacillus rhamnosus LRa05)

Lacticaseibacillus rhamnosus LRa05 · Wecare Probiotics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LRa05 (Lacticaseibacillus rhamnosus LRa05), covering 2024-11-21 to 2024-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Lacticaseibacillus Rhamnosus LRa05 for Alleviating Allergic Rhinitis in Children [NA]